NL-OMON49051招募中不适用
Gut microbial substrate switch to improve metabolic health - WholeFiber Study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 42
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Overweight/obese (BMI >= 28 kg/m2 < 35 kg/m2) with insulin resistance
- •(HOMA-IR>2.2) and/or impaired glucose tolerance (IGT: 2h plasma glucose during
- •75g OGTT 7.8-11.1 mmol/l) and/or impaired fasting glucose (IFG: plasma glucose
- •>= 5.6 mmol/l) aged 45-70 years
排除标准
- •- diabetes mellitus
- •- gastroenterological diseases or major abdominal surgery (allowed i.e.:
- •appendectomy, cholecystectomy)
- •- lactose intolerance and other digestive disorders
- •- cardiovascular disease, cancer, liver or kidney malfunction (determined based
- •on ALAT and creatinine levels,
- •respectively)
- •- disease with a life expectancy shorter than 5 years
- •- abuse of products (alcohol consumption > 15 units/week, or any drugs)
- •- excessive nicotine use defined as >20 cigarettes per day
- •- plans to lose weight or follow a hypocaloric diet
- •- regular supplement of pre- or probiotic products
- •- intensive exercise more than three hours a week
- •- - use of any medication that influences glucose or fat metabolism and
- •inflammation, like i.e. lipid
- •lowering-drugs (e.g. PPAR γ or PPARa (fibrates) agonists), glucose-lowering
- •agents (including all
- •sulfonylureas, biguanides, a-glucosidase inhibitors, thiazolidinediones,
- •repaglinide, nateglinide and insulin),
- •anti-oxidants or chronic corticosteroids treatment.
- •- use of laxation products in the last three months or during the study period
研究者
相似试验
已完成
不适用
Fiber and Insulin SensitivityObesityInsulin ResistanceNCT04714944Maastricht University Medical Center42
已完成
2 期
Modulation of small intestinal microbial composition and activity, systemic immune adaptation and blood transcriptional changes induced by 2-wks consumption with 2 fermented milk products; a randomized, exploratory, cross-over, double blind, controlled study in ileostomy patientscolectomyileostomy10017943NL-OMON45768niversiteit Maastricht16
招募中
Unknown
Study of the gut microbiota modulatory potential of two popular drinks in northern NigeriaDigestive SystemNutritional, Metabolic, EndocrineOral HealthPACTR202401853406618AUDU HARUNA JIMOH36
招募中
不适用
Fecal microbiota transplantation for improved Fructose catabolism and Insulin sensiTivity In patients with metabolic syndrome : the FFIT studyinsulin resistance/Dm2microbiota10018424NL-OMON49935Academisch Medisch Centrum56
招募中
不适用
Exploring the modulatory effects of gut microbiota on cholangiocarcinoma progression in a patient-derived organoid modelCholangiocarcinomaIntrahepatic bile duct carcinomaC22.1DRKS00033188nimedizin Mainz, Klinik für Allgemein-, Viszeral- und Transplantationschirurgie20